Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| HNI | PRESS-RELEASE | neutral | 2/10 | Allsteel, a subsidiary of HNI Corporation, announced the launch of Flourish, a new collaborative chair designed for mode | May 22, 2026 |
| XWIN | PRESS-RELEASE | bullish | 5/10 | XMax Inc. announced that its subsidiary XMax AI signed a one-year AI Model API Services Agreement with a new customer, e | May 22, 2026 |
| SJI | PRESS-RELEASE | neutral | 4/10 | South Jersey Industries amended its cash tender offer for its 3.70% Junior Subordinated Notes due 2031, raising the cons | May 22, 2026 |
| IMPP | PRESS-RELEASE | bullish | 6/10 | Imperial Petroleum reported Q1 2026 net income of $28.0M ($0.60 basic EPS), its second-best quarterly result, on revenue | May 22, 2026 |
| AGAE | PRESS-RELEASE | bearish | 8/10 | All In FutureTech Alliance (AGAE) announced a definitive agreement to acquire a 57.67% controlling interest in HyalRoute | May 22, 2026 |
| ONCY | PRESS-RELEASE | neutral | 4/10 | Oncolytics Biotech announced translational data from the GOBLET and AWARE-1 trials will be presented at ASCO 2026, showi | May 22, 2026 |
| SNAL | PRESS-RELEASE | neutral | 3/10 | Snail, Inc. issued a press release highlighting progress in partnerships with three Polish game development studios (Abo | May 22, 2026 |
| CYCU | PRESS-RELEASE | bullish | 7/10 | Cycurion (CYCU) announced the acquisition of Secuvant for ~$2.875M ($875K cash + 888,888 preferred shares) to bolster it | May 22, 2026 |
| SHIM | PRESS-RELEASE | bearish | 6/10 | Shimmick Corporation priced an underwritten public offering of 3,730,000 shares at $3.50 per share, expected to raise ne | May 22, 2026 |
| SBC | PRESS-RELEASE | neutral | 2/10 | SBC Medical Group announced a consulting partnership with BLEZ ASIA to open a new aesthetic dermatology section in Bangk | May 22, 2026 |
| AVXL | PRESS-RELEASE | bearish | 7/10 | Anavex Life Sciences disclosed a Nasdaq delinquency notice for failing to timely file its Q2 FY2026 Form 10-Q, adding to | May 22, 2026 |
| ABM | PRESS-RELEASE | neutral | 1/10 | ABM Industries Incorporated announced it will report its Q2 2026 results on June 5, 2026. | May 22, 2026 |
| FUFU | PRESS-RELEASE | neutral | 1/10 | BitFuFu Inc. announced it will report its Q1 2026 results on May 29, 2026. | May 22, 2026 |
| GSL | PRESS-RELEASE | bullish | 6/10 | Global Ship Lease reported Q1 2026 normalized EPS of $2.56, beating the $2.40 consensus by 6.7%. Operating revenue of $1 | May 22, 2026 |
| BCTXL | PRESS-RELEASE | bullish | 7/10 | BriaCell announced positive Phase 2 survival data for Bria-IMT in heavily pre-treated metastatic breast cancer, with med | May 22, 2026 |
| DXLG | PRESS-RELEASE | mixed | 7/10 | Destination XL Group (DXLG) issued a press release addressing Zodiac Partners' unsolicited $0.82/share tender offer, sta | May 22, 2026 |
| CHA | PRESS-RELEASE | neutral | 1/10 | Chagee Holdings Limited announced it will report its Q1 2026 results on May 28, 2026. | May 22, 2026 |
| ASMB | PRESS-RELEASE | neutral | 5/10 | Assembly Bio is expanding ABI-6250, an oral NTCP inhibitor in Phase 1a for HDV, into cholestatic liver diseases (PBC/PSC | May 22, 2026 |
| ACIU | PRESS-RELEASE | bullish | 6/10 | AC Immune presented Phase 1 data at the 2026 TDP43 Summit showing its TDP-43 PET tracer ACI-19626 detects higher uptake | May 22, 2026 |
| LYB | PRESS-RELEASE | neutral | 2/10 | LyondellBasell declared a quarterly dividend of $0.69 per share, payable June 8, 2026. This is a routine capital return | May 22, 2026 |
| TII | PRESS-RELEASE | neutral | 2/10 | Titan Mining appointed Matthew Melnyk as VP of Geology & Exploration and Ashley Kates as Interim CFO, following Kevin Ha | May 22, 2026 |
| BNTX | PRESS-RELEASE | neutral | 5/10 | BioNTech announced new clinical data for pumitamig (Phase 2/3 ROSETTA Lung-02 in 1L NSCLC) and gotistobart (Phase 2 PRES | May 22, 2026 |
| NGEN | PRESS-RELEASE | bearish | 6/10 | NervGen Pharma priced a $60M underwritten public offering of 24M common shares and warrants, with shares at $2.50 and wa | May 21, 2026 |
| MDLN | PRESS-RELEASE | bearish | 6/10 | Medline's PE owners (Blackstone, Hellman & Friedman, ADIA) priced a 72.6M-share secondary offering at $37.00/share, rais | May 21, 2026 |
| AGAE | PRESS-RELEASE | neutral | 4/10 | All In FutureTech Alliance (AGAE) announced it filed its overdue 2025 10-K, resolving a Nasdaq delisting threat tied to | May 21, 2026 |
| LIMN | PRESS-RELEASE | bearish | 8/10 | Liminatus Pharma received a Nasdaq delisting notice after failing to regain compliance with the $50M market value of lis | May 21, 2026 |
| RKLB | PRESS-RELEASE | bullish | 7/10 | Rocket Lab won a $90M contract from the U.S. Space Force to design, build, and operate two GEO satellites hosting the He | May 21, 2026 |
| AAPG | PRESS-RELEASE | neutral | 4/10 | Ascentage Pharma announced that six abstracts from its clinical studies were selected for presentation at the 2026 ASCO | May 21, 2026 |
| BIIB | PRESS-RELEASE | bearish | 7/10 | Biogen and Denali announced that the Phase 2b LUMA study of BIIB122 in early-stage Parkinson's disease failed to meet it | May 21, 2026 |
| DNLI | PRESS-RELEASE | bearish | 7/10 | Denali Therapeutics and Biogen announced that the Phase 2b LUMA study of BIIB122 in early-stage Parkinson's disease fail | May 21, 2026 |